Kwangdong Phar (KO:009290) — Market Cap & Net Worth
Market Cap & Net Worth: Kwangdong Phar (009290)
Kwangdong Phar (KO:009290) has a market capitalization of $213.71 Million (₩315.35 Billion) as of September 17, 2026. Listed on the KO stock exchange, this Korea-based company holds position #16373 globally and #596 in its home market, demonstrating a 0.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kwangdong Phar's stock price ₩6350.00 by its total outstanding shares 49660974 (49.66 Million). Also see 009290 total asset value for a full breakdown of the balance sheet.
Kwangdong Phar Market Cap History: 2015 to 2026
Kwangdong Phar's market capitalization history from 2015 to 2026. Data shows change from $340.87 Million to $213.71 Million (-4.94% CAGR). Also see how efficiently does Kwangdong Phar generate cash for how efficiently the company converts equity into cash flow.
Kwangdong Phar Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kwangdong Phar's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 009290 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Kwangdong Phar's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Kwangdong Phar's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $262.91 Million | $1.06 Trillion | $28.06 Billion | 0.00x | 0.01x |
| 2017 | $272.42 Million | $1.14 Trillion | $23.20 Billion | 0.00x | 0.01x |
| 2018 | $215.86 Million | $1.18 Trillion | $22.35 Billion | 0.00x | 0.01x |
| 2019 | $212.13 Million | $1.24 Trillion | $23.06 Billion | 0.00x | 0.01x |
| 2020 | $330.28 Million | $1.24 Trillion | $45.37 Billion | 0.00x | 0.01x |
| 2021 | $242.64 Million | $1.34 Trillion | $24.02 Billion | 0.00x | 0.01x |
| 2022 | $197.88 Million | $1.43 Trillion | $24.17 Billion | 0.00x | 0.01x |
| 2023 | $250.05 Million | $1.51 Trillion | $36.97 Billion | 0.00x | 0.01x |
| 2024 | $183.08 Million | $1.64 Trillion | $40.48 Billion | 0.00x | 0.00x |
| 2025 | $197.22 Million | $1.66 Trillion | $20.97 Billion | 0.00x | 0.01x |
Competitor Companies of 009290 by Market Capitalization
Companies near Kwangdong Phar in the global market cap rankings as of September 17, 2026. Review 009290 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Kwangdong Phar by market ranking:
- Nestlé S.A (F:NESM): Ranked #90 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #105 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #594 globally with a market cap of $45.87 Billion USD ( €39.23 Billion EUR).
- Danone SA (F:BSND): Ranked #693 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Nestlé S.A | F:NESM | $224.33 Billion | €82.60 |
| #105 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF77.66 |
| #594 | Danone SA | PA:BN | $45.87 Billion | €60.92 |
| #693 | Danone SA | F:BSND | $39.61 Billion | €12.00 |
Kwangdong Phar Historical Marketcap From 2015 to 2026
Between 2015 and today, Kwangdong Phar's market cap moved from $340.87 Million to $ 213.71 Million, with a yearly change of -4.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩213.71 Million | +8.36% |
| 2025 | ₩197.22 Million | +7.72% |
| 2024 | ₩183.08 Million | -26.78% |
| 2023 | ₩250.05 Million | +26.37% |
| 2022 | ₩197.88 Million | -18.45% |
| 2021 | ₩242.64 Million | -26.53% |
| 2020 | ₩330.28 Million | +55.69% |
| 2019 | ₩212.13 Million | -1.72% |
| 2018 | ₩215.86 Million | -20.76% |
| 2017 | ₩272.42 Million | +3.62% |
| 2016 | ₩262.91 Million | -22.87% |
| 2015 | ₩340.87 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Kwangdong Phar was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $213.71 Million USD |
| MoneyControl | $213.71 Million USD |
| MarketWatch | $213.71 Million USD |
| marketcap.company | $213.71 Million USD |
| Reuters | $213.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kwangdong Phar
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more